Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy
- PMID: 30513238
- PMCID: PMC6663126
- DOI: 10.1080/21645515.2018.1551673
Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy
Abstract
Rotavirus (RV) diarrhea is one of the most common cause of childhood morbidity and mortality in the world. The World Health Organization has recommended RV vaccines' use in national immunization programs since 2009. However, access to vaccines remain limited, particularly for most low- and middle-income countries where the burden of the disease is high. The Philippines is a lower-middle income country in Asia where RV vaccination remains limited. Recent studies in the Philippines indicate an estimated vaccine effectiveness of 60% against RV hospitalization, and a 50-60% reduction of all cause diarrhea among children aged under 5 within the population. Furthermore, we estimate that 225 rotavirus cases can be prevented per 1000 children vaccinated against RV. This information will be crucial as policymakers decide on expanding RV vaccination nationwide.
Keywords: Philippines; diarrhea; immunization; rotavirus; rotavirus vaccine.
Figures
Similar articles
-
Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.Vaccine. 2018 Dec 14;36(51):7769-7774. doi: 10.1016/j.vaccine.2017.10.058. Epub 2017 Oct 26. Vaccine. 2018. PMID: 29107346 Free PMC article.
-
Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.Vaccine. 2015 May 7;33 Suppl 1:A192-200. doi: 10.1016/j.vaccine.2014.12.035. Vaccine. 2015. PMID: 25919160
-
Cost-effectiveness of rotavirus vaccination in Turkey.J Microbiol Immunol Infect. 2017 Oct;50(5):693-699. doi: 10.1016/j.jmii.2016.03.005. Epub 2016 Mar 31. J Microbiol Immunol Infect. 2017. PMID: 27107612
-
Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.Expert Rev Vaccines. 2012 Feb;11(2):211-20. doi: 10.1586/erv.11.184. Expert Rev Vaccines. 2012. PMID: 22309669 Review.
-
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.Expert Rev Vaccines. 2021 Dec;20(12):1499-1514. doi: 10.1080/14760584.2020.1853532. Epub 2021 Apr 20. Expert Rev Vaccines. 2021. PMID: 33275065 Review.
Cited by
-
Comparison of IgA Antibody Titer Induced by Human-Bovine Rotavirus Candidate Vaccine with Bovine Rotavirus and Rotarix.Arch Razi Inst. 2023 Feb 28;78(1):405-412. doi: 10.22092/ARI.2021.354821.1652. eCollection 2023 Feb. Arch Razi Inst. 2023. PMID: 37312718 Free PMC article.
-
Genomic Constellation of Human Rotavirus G8 Strains in Brazil over a 13-Year Period: Detection of the Novel Bovine-like G8P[8] Strains with the DS-1-like Backbone.Viruses. 2023 Mar 1;15(3):664. doi: 10.3390/v15030664. Viruses. 2023. PMID: 36992373 Free PMC article.
-
Projecting Temperature-Attributable Mortality and Hospital Admissions due to Enteric Infections in the Philippines.Environ Health Perspect. 2022 Feb;130(2):27011. doi: 10.1289/EHP9324. Epub 2022 Feb 21. Environ Health Perspect. 2022. PMID: 35188405 Free PMC article.
-
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.Vaccine. 2021 Apr 8;39(15):2048-2059. doi: 10.1016/j.vaccine.2021.03.033. Epub 2021 Mar 18. Vaccine. 2021. PMID: 33744044 Free PMC article.
-
Vaccines for enteric diseases.Hum Vaccin Immunother. 2019;15(6):1205-1214. doi: 10.1080/21645515.2019.1611200. Hum Vaccin Immunother. 2019. PMID: 31291174 Free PMC article. No abstract available.
References
-
- G. B. D. Diarrhoeal Disease Collaborators Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018. doi:10.1016/S1473-3099(18)30362-1. - DOI - PMC - PubMed
-
- Troeger C, Colombara DV, Rao PC, Khalil IA, Brown A, Brewer TG, Guerrant RL, Houpt ER, Kotloff KL, Misra K, et al. Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. Lancet Glob Health. 2018;6:e255–e269. doi:10.1016/S2214-109X(18)30045-7. - DOI - PMC - PubMed
-
- Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172:958–965. doi:10.1001/jamapediatrics.2018.1960. - DOI - PMC - PubMed
-
- World Health Organization Rotavirus vaccines: an update. Wkly Epidemiol Rec. 2009;84:533–540. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical